The investment seeks long-term capital growth; income is a secondary consideration... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapValue
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFDGX | 55.81 | 0.29 | +0.52% |
American Century Large Cap Equity R5 | |||
FLDGX | 14.61 | 0.04 | +0.27% |
Meeder Dynamic Allocation Retail | |||
GPIGX | 13.50 | 0.03 | +0.20% |
Guidepath® Growth and Income | |||
ETNHX | 34.00 | -0.01 | -0.03% |
Eventide Healthcare & Life Sciences N | |||
REEBX | 60.20 | -0.32 | -0.53% |
American Funds EUPAC R2E |
A.I.dvisor indicates that over the last year, AVUAX has been closely correlated with VMVIX. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVUAX jumps, then VMVIX could also see price increases.
Ticker / NAME | Correlation To AVUAX | 1D Price Change % | ||
---|---|---|---|---|
AVUAX | 100% | +0.30% | ||
VMVIX - AVUAX | 89% Closely correlated | +0.66% | ||
VMVAX - AVUAX | 89% Closely correlated | +0.66% | ||
VEVYX - AVUAX | 81% Closely correlated | +0.32% | ||
JVMRX - AVUAX | 74% Closely correlated | +0.61% | ||
JVMIX - AVUAX | 74% Closely correlated | +0.61% | ||
More |